Institutional investors purchased a net $3.0 million shares of INVA during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 80.01% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SARISSA CAPITAL MANAGEMENT LP Bought 1.0 Million shares of Innoviva Inc
CITADEL ADVISORS LLC Bought 658.2 Thousand shares of Innoviva Inc